×
模态框（Modal）标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框（Modal）标题
在这里添加一些文本
Close
×
Please choose a citation manager
RIS (ProCite, Reference Manager)
BibTeX
Content to export
Citation
Citation and abstract
Export
ISSN 1008-5734
CN 11-4015/R
1999年创刊
主管: 中国科学技术协会
主办: 中华医学会
Toggle navigation
Home
About Journal
Editorial Board
Subscription
Submission
Download
FAQ
Conference
中文
Hot Article
More...
WeChat
Most Read
More...
Most Download
More...
Office
Online Submission
Manuscript Tracking
Editor Work
Office Work
Editor-in-Chief
Journal
Earlier Issues
Current Isue
Advanced Search
Browse by Column
Archive
Most Read
Most Download
Email Alert
RSS
Download
More...
Link
More...
Current Issue
Archive
2025,Vol. 27 No. 1 Published: 28 January 2025
Anticoagulant-related nephropathy: a clinical risk to be vigilant
Zhang Jinhua, Niu Peiguang
2025, 27(1): 2-5.
https://doi.org/10.3760/cma.j.cn114015-20241023-00112
Abstract (
)
PDF
(
)
A retrospective cohort study on the effect of concomitant amiodarone on bleeding risk in atrial fibrillation patients with dabigatran etexilate treatment
Wei Anhua, Wang Lu, Zeng Lu, Li Wei, Gong Xuepeng, Liu Dong
2025, 27(1): 6-10.
https://doi.org/10.3760/cma.j.cn114015-20240603-00409
Abstract (
)
PDF
(
)
Risk of kidney injury due to oral anticoagulants: a study based on FDA Adverse Event Reporting System database
Peng Wenxing, Chen Guoquan, Ding Zheng
2025, 27(1): 11-16.
https://doi.org/10.3760/cma.j.cn114015-20240430-00296
Abstract (
)
PDF
(
)
Analysis of severe medication errors of tranexamic acid injection and prevention suggestions
Li Siyan, Zhang Qingxia, Medication Safety Panel in China Core Group of International Network for the Rational Use of Drugs
2025, 27(1): 17-24.
https://doi.org/10.3760/cma.j.cn114015-20240715-00570
Abstract (
)
PDF
(
)
Risk signal mining of adverse events of satralizumab treatment for neuromyelitis optica spectrum disorder: based on the US Food and Drug Administration Adverse Event Reporting System
Shi Huahui, Ji Chunmei
2025, 27(1): 25-29.
https://doi.org/10.3760/cma.j.cn114015-20240531-00407
Abstract (
)
PDF
(
)
Construction of perioperative clinical medicine pathway system based on work breakdown structure
Xing Xiaomin, Han Bing, Liu Donghua, Yue Yue, Zhu Li, Leng Ping, Li Jing
2025, 27(1): 30-35.
https://doi.org/10.3760/cma.j.cn114015-20240516-00348
Abstract (
)
PDF
(
)
Research progress on the effects of anti-retroviral agents on glucose and lipid metabolism and body weight in patients with human immunodeficiency virus infection
Xiao Ran, Du Xiaoli, Li Taisheng
2025, 27(1): 36-43.
https://doi.org/10.3760/cma.j.cn114015-20240402-00219
Abstract (
)
PDF
(
)
Research progress on risk of major adverse cardiovascular events associated with Janus kinase inhibitors in treatment of immune-mediated inflammatory diseases
Zhao Danjie, Bian Yuan, Yin Qi'nan, Wang Yi, Tang Peng, Han Lizhu
2025, 27(1): 44-49.
https://doi.org/10.3760/cma.j.cn114015-20240513-00338
Abstract (
)
PDF
(
)
Severe liver injury induced by
Tongtian
oral solution(通天口服液) combined with
Yangxue
Qingnao
pills(养血清脑丸)
Niu Xiaoqiang
2025, 27(1): 50-52.
https://doi.org/10.3760/cma.j.cn114015-20240528-00383
Abstract (
)
PDF
(
)
Idarucizumab for reversal of dabigatran etexilate-induced gastrointestinal bleeding
Lin Qi, Dong Shujie, Li Lei, Wang Kun, Shi Junbao, Yang Li
2025, 27(1): 53-55.
https://doi.org/10.3760/cma.j.cn114015-20240304-00129
Abstract (
)
PDF
(
)
Gastric retention and ketoacidosis induced by combined use of semaglutide and empagliflozin
Lu Yun, Cao Fang, Tang Zhenghe
2025, 27(1): 56-58.
https://doi.org/10.3760/cma.j.cn114015-20240318-00177
Abstract (
)
PDF
(
)
Low-dose methylprednisolone treatment for immune-associated colitis induced by sintilimab
Tang Wenjun, Yan Qixing
2025, 27(1): 59-61.
https://doi.org/10.3760/cma.j.cn114015-20240402-00220
Abstract (
)
PDF
(
)
